Correspondence: The ethics of noninferiority trials.
Abstract
This brief Correspondence item responds to criticism of non-inferiority trials, and suggests that research to develop new drugs for treatment of drug-sensitive tuberculosis is an appropriate use of such trials.
Citation
Lancet (2008) 371 (9616, 15 March) 895
Links
Published 1 January 2008